Assessment of dental care during the covid-19 pandemic in Turkey and future projections
DOI:
https://doi.org/10.14295/bds.2020.v23i2.2260Abstract
ABSTRACT
A new coronavirus disease has affected the whole world, starting from Wuhan, China at the end of 2019. The disease, caused by the pathogen of SARS-CoV-2, commonly called COVID-19, has soon passed into the history of epidemics as the most effective pandemic recently. Dentistry has also been significantly affected by the pandemic process, which had a restrictive effect on almost all aspects of social life. Dental treatments are healthcare services that have been applied very carefully in terms of the risk control of cross-infection prior to this pandemic where disinfection and sterilization rules continue to be controlled at the highest level. However, hand instruments used in most dental treatments and generating aerosol has raised concerns, particularly in diseases such as COVID-19, which increase the risk of droplet contamination. This working order is an important risk factor not only for healthcare professionals but also for the contamination of patients and the environment. In addition, the continuing pandemic process and the dynamics of the process require revision of the protocols. For this reason, each country has prepared protocols in order to maintain the dental treatments in the pandemic process in accordance with their own health care conditions and policies.This process caused the dental professionals to reconsider their routine working practices and prospectively, new protocols are recommended for dental applications. This article aims to provide a perspective evaluating the current situation and discuss additional measures to be considered during the pandemic and thereafter.
KEYWORDS
Coronavirus; SARS-CoV-2; COVID-19 Pandemic; Dentistry; Infection Control, Transmission.
Author Biography
Mutlu Özcan, (Reconstructive Science) - University of Zurich, Dental Materials Unit, Switzerland
MUTLU ÖZCAN, Prof. Dr. Dr.med.dent., h.c., Ph.D
Date of Birth: June, 17th, 1969
1993 Licenciate in Dentistry (DDS, Marmara University, İstanbul)
1999 Dr.med.dent. (Medical and Dental School of Cologne, Germany)
2001-2002 Invited visiting researcher (University of Turku, Department of Prosthetic Dentistry and Biomaterials Research, Finland)
2003 Doctorate in Medical Sciences (Ph.D) (Royal University of Groningen, Department of Dentistry and Dental Hygiene, The Netherlands)
2007-present Professor at the Clinical Dental Biomaterials (University Medical Center Groningen, Department of Dentistry and Dental Hygiene, The Netherlands)
2009-present Professor and Head of Division of Dental Biomaterials (University of Zurich, Center for Dental and Oral Medicine, Clinic for Fixed and Removable Prosthodontics and Dental Materials Science, Zurich, Switzerland)
She has authored more than 500 scientific and clinical articles in peer-reviewed journals, is a well-sought lecturer, receiver of several international awards and has held numerous continuing education courses in Europe. She serves also for the editorial boards of several scientific journals. Her clinical expertise is on reconstructive dentistry and her scientific work focuses on translational research.
She has Honorary Professorship positions at various universities some of which are São Paolo State University (Brazil), University of Florida (USA) and University of Hong Kong (China).
She is EPA-Recognized Specialist in Prosthodontics, Honorary Secretary of the European Prosthodontic Association (EPA), Past-President of the International Association of Dental Research (IADR) / Dental Materials Group (DMG), Fellow of Academy of Dental Materials (FADM), Fellow of International College of Dentistry (FICD) and Fellow in Dental Surgery of the Royal College of Physicians and Surgeons of Glasgow, FDS RCPS (Glasgow).
In 2018, she received “Dr. honoris causa” title from Romania.
She is the recipient of the “2018 IADR Distinguished Scientist Wilmer Souder Award”.
References
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Mar;382(13):1199-207. doi: 10.1056/NEJMoa2001316
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb;382(8):727-33. doi: 10.1056/NEJMoa2001017
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb;395(10223): 470–3. doi: 10.1016/S0140-6736(20)30185-9.
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb;395(10223):514–23. doi: 10.1016/S0140-6736(20)30154-9
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Mar;382(10):929-36. doi: 10.1056/NEJMoa2001191
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020 Mar;382(10):970-1. doi: 10.1056/NEJMc2001468
Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res. 2020 May;99(5):481-7. doi: 10.1177/0022034520914246
Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5):2000062. doi:10.2807/1560-7917.ES.2020.25.5.2000062
Lai CC, Liu YH, Wang CY, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020;. doi:10.1016/j.jmii.2020.02.012
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb;395(10223):507–13. doi: 10.1016/S0140-6736(20)30211-7
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020 Apr;382(18):1708-20. doi: 10.1056/NEJMoa2002032
Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020;ciaa330. doi:10.1093/cid/ciaa330
Wu Z, McGoogan JM. Characteristics of and ımportant lessons from the coronavirus disease 2019 (covıd-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;10.1001/jama.2020.2648. doi:10.1001/jama.2020.2648
Wang D, Hu B, Hu C, et al. clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-ınfected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061‐9. doi:10.1001/jama.2020.1585
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J (Engl). 2020 May;133(9):1025-31. doi: 10.1097/CM1099.0000000000000744
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when novel coronavirus (2019-nCoV) infection is suspected: interim guidance; 13 March 2020 [Internet]. WHO. [cited 2020 May 19]. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infec tion-when-novel-coronavirus-(ncov)-infection-is-suspected.
Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020;130(4):1545‐8. doi:10.1172/JCI138003
Izzetti R, Nisi M, Gabriele M, Graziani F. COVID-19 transmission in dental practice: brief review of preventive measures in Italy. J Dent Res. 2020;22034520920580. doi:10.1177/0022034520920580
Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;12(1):9. doi:10.1038/s41368-020-0075-9
Alharbi A, Alharbi S, Alqaidi S. Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dent J. 2020;32(4):181‐6. doi:10.1016/j.sdentj.2020.04.001
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246‐51. doi:10.1016/j.jhin.2020.01.022
Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM. Coronavirus disease 19 (COVID-19): ımplications for clinical dental care. J Endod. 2020;46(5):584‐95. doi:10.1016/j.joen.2020.03.008
Li ZY, Meng LY. Prevention and control of new coronavirus infection in department of stomatology. Chin J Stomatol. 2020;55(0):E001. doi:10.3760/cma.j.issn.1002-0098.2020.0001.
Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther 2018 Jun; 7(2):249–59. doi: 10.1007/s40121-018-0200-7
Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006;212 Suppl 1(Suppl 1):119‐23. doi:10.1159/000089211
